Alpha 2.0
Login Register
» Articles » PMID: 39788487

Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022-2023

Overview
Journal J Am Med Dir Assoc
Publisher Elsevier
Date 2025 Jan 9
PMID 39788487
Authors
Arshiya Patel
Amanda B Payne
Dustin W Currie
Thomas Franceschini
Amber Gensheimer
Joseph D Lutgring
Sujan C Reddy
Sujan Reddy
Kelly M Hatfield
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aimed to evaluate the utility of electronic health record (EHR) diagnosis codes for monitoring SARS-CoV-2 infections among nursing home residents.

Design: A retrospective cohort study design was used to analyze data collected from nursing homes operating under the tradename Signature Healthcare between January 2022 and June 2023.

Setting And Participants: Data from 31,136 nursing home residents across 76 facilities in Kentucky, Tennessee, Indiana, Ohio, North Carolina, Georgia, Alabama, and Virginia were included.

Methods: Resident demographics, diagnosis codes associated with clinical diagnoses (including COVID-19), and SARS-CoV-2 testing information were collected from the EHR and supplemental testing data sources. We described the rates of infection and the clinical characteristics of residents with incident-positive SARS-CoV-2 tests and new-onset COVID-19 diagnoses. Positive predictive values (PPVs) of COVID-19 diagnosis codes were calculated for residents stratified by whether a resident was continuously present in a facility for ±3 days from the diagnosis onset date listed in EHRs, using positive SARS-CoV-2 tests to confirm infection.

Results: A total of 4876 incident-positive SARS-CoV-2 tests and 6346 new-onset COVID-19 diagnoses were recorded during the study period. Weekly rates of new-onset diagnoses were significantly higher than positive test rates, although trends followed similar trajectories. Among residents continuously present in the nursing home ±3 days from the diagnosis onset date, the PPV of COVID-19 diagnosis codes was high (3395 of 3685 = 92%; 95% CI, 91%-93%). The PPV among this group significantly varied by study quarter (P < .001). The PPV was substantially lower for 2661 diagnoses among residents not continuously present in the nursing home (24%; 95% CI, 22%-26%).

Conclusions And Implications: This study demonstrates the utility of diagnosis codes for assessment of COVID-19 epidemiology and trends when testing data are unavailable for residents during their stay in a nursing home. Future research should explore strategies to evaluate the utility of diagnosis codes at admission and discharge to nursing homes to enhance surveillance efforts.

References
1.
Dutey-Magni P, Williams H, Jhass A, Rait G, Lorencatto F, Hemingway H . COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March-June 2020). Age Ageing. 2021; 50(4):1019-1028. PMC: 7989651. DOI: 10.1093/ageing/afab060. View
2.
Adler-Milstein J, Raphael K, OMalley T, Cross D . Information Sharing Practices Between US Hospitals and Skilled Nursing Facilities to Support Care Transitions. JAMA Netw Open. 2021; 4(1):e2033980. PMC: 7809587. DOI: 10.1001/jamanetworkopen.2020.33980. View
3.
Kluberg S, Hou L, Dutcher S, Billings M, Kit B, Toh S . Validation of diagnosis codes to identify hospitalized COVID-19 patients in health care claims data. Pharmacoepidemiol Drug Saf. 2021; 31(4):476-480. DOI: 10.1002/pds.5401. View
4.
Bhatt A, McElrath E, Claggett B, Bhatt D, Adler D, Solomon S . Accuracy of ICD-10 Diagnostic Codes to Identify COVID-19 Among Hospitalized Patients. J Gen Intern Med. 2021; 36(8):2532-2535. PMC: 8183587. DOI: 10.1007/s11606-021-06936-w. View
5.
Link-Gelles R, Britton A, Fleming-Dutra K . Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions. Vaccine. 2023; 42 Suppl 3:125492. PMC: 11304400. DOI: 10.1016/j.vaccine.2023.12.002. View